Fmoc-D-HoArg-OH.HCl

Catalog No.: 
ACLEPB431
CAS No.: 
1998701-39-5
Molecular Formula: 
C22H27ClN4O4
Molecular Weight: 
446.93
Fmoc-D-HoArg-OH.HCl structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$189.00In stockInquiry
25g98%$926.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-D-HoArg-OH.HCl
IUPAC NameN2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(diaminomethylene)-D-lysine hydrochloride
MDL No.MFCD30475798
Molecular FormulaC22H27ClN4O4
Molecular Weight446.93
SMILESO=C(O)[C@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)CCCCNC(N)=N.[H]Cl
InChI KeyCIHMGZUUYMRKGJ-FSRHSHDFSA-N
Synonym(9H-Fluoren-9-yl)MethOxy]Carbonyl D-HoArg-OH·HCl;(2R)-6-carbamimidamido-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid hydrochloride
CAS No.1998701-39-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLEPB431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPAAI301 route compound structure diagram
    ACPAAI301110798-13-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLEPB431 route product structure diagram
    ACLEPB4311998701-39-5In Stock
Inquiry

2. ACLEPB431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLEPB431 route product structure diagram
    ACLEPB4311998701-39-5In Stock
Inquiry

3. ACLEPB431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLEPB431 route product structure diagram
    ACLEPB4311998701-39-5In Stock
Inquiry

Comments (0)